Utilising enzyme-free DNA nanotechnology, immunoMUSE® kits from Amsbio enable researchers to perform ultra-sensitive, 2-plex to 4-plex custom biomarker detection in tissue while generating same-day imaging results without species or isotype constraints.
As senior scientist within LifeArc’s Molecular and Cellular Pharmacology (MCP) department, you will be part of a diverse group of scientists with a wealth of experience in the preclinical phase of drug discovery. MCP focuses on developing and applying bespoke biological cell-based assays for characterisation and screening of therapeutic assets, providing a deep understanding of their complex mechanism of action to support LifeArc’s ambitious goals to benefit patients and to make life science life changing.
We are looking for an exceptional scientist with a research focus on ensuring food safety and security.
About Vernalis
Working within our fully equipped research laboratories in Cambridge, our established group of scientists are world leaders in multiple hit-ID technologies and structure-based drug discovery.
Our scientists develop and apply lead generation and structure-based methods to solve problems in drug discovery and have generated cell active compounds and development candidates against targets in multiple therapeutic areas including oncology, neurodegeneration, anti-infectives and inflammation.
The Role
Revvity | About Us
Revvity is a developer and provider of end-to-end solutions designed to help scientists, researchers, and clinicians solve the world’s greatest health challenges. We pair the enthusiasm of an industry disruptor with the experience of a longtime leader. Our team of 11,000+ colleagues from around the globe are vital to our success and the reason we’re able to push boundaries in pursuit of better human health.
Find your future at Revvity.
The Rosalind Franklin Institute (the Franklin) is a technology institute established by the UK Government as a unique centre committed to advancing tools that are needed to transform healthcare in the future.
Job type: Full-time
Location: Oxford, with hybrid working options available
Right to work: You must have the right to work in the UK
A new funded programme will support start-ups applying structural chemistry data, AI and machine learning to solve real-world scientific challenges
The Cambridge Crystallographic Data Centre (CCDC) today announced the launch of the CCDC Innovation Fund, a new seed funding programme designed to support emerging companies developing innovative solutions in structural chemistry.
Company Description
Scarlet Therapeutics is a biotechnology company developing transformative therapies. Building on more than a decade of world-renowned research in Bristol, UK, the team at Scarlet is pioneering unique technology to harness the potential of blood as medicine, positioning the company to become the global leader in the field of therapeutic red blood cells.